RECURSION PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $15.7M |
| FY2019 | — | — | $75.2M |
| FY2020 | $56.6M | $298.6M | $262.1M |
| FY2021 | $67.4M | $610.3M | $285.1M |
| FY2022 | $215.5M | $701.3M | $549.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $15.7M |
| FY2019 | — | — | $75.2M |
| FY2020 | $56.6M | $298.6M | $262.1M |
| FY2021 | $67.4M | $610.3M | $285.1M |
| FY2022 | $215.5M | $701.3M | $549.9M |